Found: 15
Select item for more details and to access through your institution.
Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 991, doi. 10.1007/s13300-021-01004-2
- By:
- Publication type:
- Article
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1159, doi. 10.1007/s13300-021-01031-z
- By:
- Publication type:
- Article
Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1193, doi. 10.1007/s13300-021-01038-6
- By:
- Publication type:
- Article
Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1209, doi. 10.1007/s13300-021-01024-y
- By:
- Publication type:
- Article
Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1175, doi. 10.1007/s13300-021-01018-w
- By:
- Publication type:
- Article
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1073, doi. 10.1007/s13300-021-01030-0
- By:
- Publication type:
- Article
A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1129, doi. 10.1007/s13300-021-01029-7
- By:
- Publication type:
- Article
The Effects of Dietary Nutrition Intake on Glycemic Variability in Type 1 Diabetes Mellitus Adults.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1055, doi. 10.1007/s13300-021-01028-8
- By:
- Publication type:
- Article
Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1143, doi. 10.1007/s13300-021-01026-w
- By:
- Publication type:
- Article
Ten-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Patients with Type 2 Diabetes Mellitus Suffering from Left Main Coronary Disease: A Meta-Analysis.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1041, doi. 10.1007/s13300-021-01025-x
- By:
- Publication type:
- Article
Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1029, doi. 10.1007/s13300-021-01023-z
- By:
- Publication type:
- Article
Fasting Blood Glucose and 2-h Postprandial Blood Glucose Predict Hypertension: A Report from the REACTION Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1117, doi. 10.1007/s13300-021-01019-9
- By:
- Publication type:
- Article
Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 969, doi. 10.1007/s13300-021-01021-1
- By:
- Publication type:
- Article
Oral Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1099, doi. 10.1007/s13300-020-00994-9
- By:
- Publication type:
- Article